Meta's $95B Financing Plan Explained: Impact on Shareholders & META Stock

 

The financing package Meta priced on October 26, 2026 has three parts totalling up to roughly $95 billion, yet the cash from those parts arrives across a span of more than a year, and the largest component has not been agreed at all.

 

Two parts are priced, totalling about $37.5 billion. One is $12.5 billion of 6.50% Series A Mandatory Convertible Preferred Stock, sold as 250 million depositary shares at $50.00 each, with proceeds arriving at closing on October 29. The other is $25.0 billion of Class A common stock at $625.00 per share, covering 40 million shares, but structured through forward sale agreements under which Meta receives nothing at the initial sale and instead collects roughly $24.9 billion on settlement dates of its own choosing, no later than November 19, 2027.

 

The third part is an at-the-market programme of up to $60 billion in Class C stock, not expected to begin before the first quarter of 2027 and only after Class C shares start trading. No agreement has been signed, its timing, size and terms are all open, and the pricing announcement does not mention it.

 

So within the $95 billion headline, roughly $12.5 billion actually lands in October 2026, around 13%. Meta's capital expenditure in the third quarter of 2026 alone reached $34.91 billion, exceeding the same period's operating cash flow of $32.786 billion for the first time. This article works through each instrument's terms, the cash arrival schedule and each path to dilution.

 

 

 

The three parts deliver cash at entirely different times. Roughly $12.5 billion from the preferred arrives at closing on October 29, roughly $24.9 billion from the forward sale arrives by November 19, 2027 at the latest, and the $60 billion ATM has no agreement.

 

The mandatory convertible carries a 6.50% dividend rate. Calculated on the $1,000 liquidation preference per share, payable quarterly from February 15, 2027 through August 15, 2029, in cash, Class A common stock or a combination.

 

The number of shares on conversion is a range rather than a fixed figure. Each preferred share converts into 1.3620 to 1.6000 Class A shares, depending on the volume-weighted average price over twenty trading days before conversion in 2029.

 

Dilution moves inversely to the share price. Derived from the contract terms, a price below $625.00 triggers the maximum conversion rate and the most shares, while a price above roughly $734.21 triggers the minimum rate and the fewest.

 

The priced portion dilutes by roughly 2.2% to 2.7%. Calculated on the 2.556 billion share base as of September 30, including the scenario where both over-allotment options are fully exercised.

 

Third-quarter capital expenditure exceeded operating cash flow for the first time. $34.91 billion against $32.786 billion, producing negative free cash flow of $2.12 billion against roughly positive $10.6 billion a year earlier.

 

The indications of interest from Nvidia, AMD and Broadcom are non-binding. The three together indicated interest in up to $5.0 billion of Class A shares on the same terms as other investors, but may buy more, less or nothing.

 

 

The three differ in legal character, cash timing and dilution mechanism, so treating them as one number produces wrong conclusions.

 

 

 

This component covers 250 million depositary shares priced at $50.00 each, with each representing a 1/20th interest in a share of 6.50% Series A Mandatory Convertible Preferred Stock carrying a $1,000 liquidation preference. Underwriters hold a thirty-day option for up to 37.5 million additional depositary shares. Expected net proceeds are roughly $12.5 billion, or roughly $14.3 billion with the option exercised in full.

 

The dividend rate is 6.50% per annum on the $1,000 liquidation preference, payable on February 15, May 15, August 15 and November 15 from February 15, 2027 through August 15, 2029, when, as and if declared by the board. Dividends may be paid in cash, in Class A common stock or in a combination, subject to certain limitations.

 

The mandatory conversion date is expected to be on or about August 15, 2029. Each preferred share converts into 1.3620 to 1.6000 Class A shares, corresponding to 0.0681 to 0.0800 per depositary share. The applicable rate depends on the volume-weighted average price of Class A stock over a twenty-trading-day final averaging period beginning on the twenty-first scheduled trading day before August 15, 2029. The preferred has been applied for listing on the Nasdaq Global Select Market under the symbol METAM, and no public market exists yet.

 

The filing also notes that once Class C common stock is issued and other conditions are met, conversion may instead be into Class C shares within the same minimum and maximum rates.

 

 

This component was upsized at pricing from $22.5 billion to $25.0 billion at $625.00 per share, covering 40 million Class A shares, or 46 million if the underwriters' thirty-day option is exercised in full and additional forward agreements are entered. The over-allotment option covers up to $3.75 billion of additional Class A shares.

 

The structure is what matters. The forward purchasers are Morgan Stanley Capital Services LLC and Goldman Sachs & Co. LLC, with an initial forward price of approximately $622.92 per share. Meta does not expect to receive proceeds from the forward purchasers' initial sales. Instead it expects to receive roughly $24.9 billion before expenses on one or more settlement dates of its own specification, no later than November 19, 2027, or roughly $28.7 billion if the option is exercised in full.

 

What this means is that the economic terms of the shares were fixed in the market on the pricing date, while both the company's cash inflow and the formal issuance of shares are deferred to a future date the company chooses. The filing also states that once Class C common stock is issued and other conditions are met, the agreements will reference both share classes, and that in certain circumstances Meta may settle all of them with Class C shares.

 

 

This is the largest and least settled of the three, capped at $60 billion in non-voting Class C stock.

 

The programme is not expected to begin before the first quarter of 2027 and only after Class C shares start trading. As of this article's verification date no agreement has been signed and the timing, size and terms are all undetermined. Note particularly that the pricing announcement of October 26 does not mention the programme at all, since it comes from the financing framework disclosed around the same time rather than from the priced documents.

 

The programme also sits at the end of a dependency chain. Per our earlier explainer on Meta's Class C shares and voting rights, January 19, 2027 is the expected effective date of the amended certificate of incorporation in Delaware rather than the date the split completes or Class C shares begin trading, while the record and payment dates for the stock dividend remain unannounced, as do the Class C ticker and listing date. The ATM's start depends on Class C trading beginning, and that date itself has not been set.

 

Worth recording as well: that article published on October 22, when the CFO said there were no specific financing plans to announce. The framework disclosed five days later gives an indicated size, yet whether, when and how much Class C stock will be issued to raise capital remains unanswered until an agreement is signed.

 

 

Laying the three components on a timeline shows the distance between the headline number and the money.

 

 

On that schedule, the $95 billion headline corresponds to roughly $12.5 billion of actual cash in October 2026, around 13%. Even the fully priced $37.5 billion does not land in full until some point before November 2027.

 

Both offerings are expected to close on October 29, and neither is conditioned on completion of the other. Morgan Stanley and Goldman Sachs are lead joint bookrunning managers, with Allen & Company, BDT & MSD, Centerview Partners, Jefferies, Lazard and The Raine Group as co-managers. Proceeds are for general corporate purposes, as are the net proceeds from future forward settlements.

 

Nvidia, AMD and Broadcom indicated interest in purchasing up to $5.0 billion of Class A shares in aggregate on the same terms as other investors, though the indications are non-binding and the three may buy more, less or nothing. The arrangement deserves separate note, since all three are also principal suppliers to Meta's AI infrastructure.

 

 

Per the prospectus supplement, Meta had 2,214 million Class A shares and 342 million Class B shares outstanding as of September 30, 2026, totalling 2,556 million. Excluded are 154 million Class A shares subject to outstanding restricted stock unit awards or stock options and 445 million Class A shares reserved for issuance under the equity incentive plan.

 

On a 2,556 million share base, the dilution paths work out as follows. The percentages below are this article's calculations from published terms, not figures stated in the filings.

 

 

The $60 billion ATM cannot be modelled precisely, since neither its price nor its timing is determined. As a rough illustration only, $60 billion at this offering's $625.00 price would correspond to roughly 96 million shares, around 3.76% of the existing count, meaning an unsigned programme carries potential dilution exceeding all the priced instruments combined. All three components fully realised would reach roughly 6.0% to 6.5%, though that figure depends on several unsettled conditions and should not be treated as a forecast.

 

 

The mandatory convertible's conversion rate is a range rather than a fixed figure, so the number of shares ultimately issued depends on the 2029 share price, and in the direction opposite to intuition.

 

Two key prices can be derived from the liquidation preference and the rate range. The maximum rate of 1.6000 corresponds to $1,000 divided by 1.6000, or $625.00, which is exactly this offering's Class A price. The minimum rate of 1.3620 corresponds to $1,000 divided by 1.3620, or roughly $734.21, about 17.5% above $625.00. Both figures are derived from the terms and are not stated directly in the pricing announcement.

 

Three cases follow. A price below $625.00 at conversion in 2029 applies the maximum rate of 1.6000, issuing the most shares, with holders bearing the full decline. A price between $625.00 and roughly $734.21 leaves the rate floating so holders receive a relatively fixed conversion value. A price above roughly $734.21 applies the minimum rate of 1.3620, issuing the fewest shares, with holders participating only in the appreciation above that threshold.

 

For existing shareholders, the implication is that the heaviest dilution arrives precisely when the share price has performed worst. That differs fundamentally from a common stock offering, where the share count is fixed at issuance.

 

One secondary source of dilution also applies. The preferred dividend may be paid in Class A common stock, so electing stock payment would add shares. On the $12.5 billion size, 6.50% corresponds to roughly $810 million a year across eleven quarters from February 2027 to August 2029. Whether and how much is paid in stock depends on the board's decision at the time.

 

 

The financing size only means something placed next to the spending.

 

 

The third quarter marked the first time capital expenditure exceeded operating cash flow for the same period, by $2.124 billion, matching the negative $2.120 billion of free cash flow. Capital expenditure a year earlier was roughly $19.4 billion, so the figure rose roughly 80%, while the first three quarters of 2026 totalled $85.8 billion against $50.1 billion a year earlier, an increase of roughly 71%.

 

Full-year 2026 capital expenditure guidance stands at $135 billion to $145 billion including principal payments on finance leases, narrowed from $130 billion to $145 billion. That implies fourth-quarter spending of roughly $49.2 billion to $59.2 billion in a single quarter.

 

That calculation gives a yardstick for this financing. At the fourth quarter's implied quarterly rate, the full $95 billion maximum corresponds to roughly one and a half to two quarters of capital expenditure, while the roughly $12.5 billion actually arriving in October 2026 amounts to under four tenths of a single third-quarter figure.

 

Note that the company has given no 2027 capital expenditure figure, saying only that it expects to keep investing aggressively in 2027, alongside a 2027 Reality Labs loss estimate of around $15 billion. Fourth-quarter revenue guidance is $73 billion to $76 billion.

 

The capital expenditure basis matters here. Meta's guidance and disclosure both use a basis including principal payments on finance leases, and its free cash flow calculation subtracts both purchases of property and equipment and finance lease principal. Against a basis counting only property and equipment, the first runs $964 million higher in the third quarter. Comparisons across companies or periods using inconsistent bases will produce skewed conclusions.

 

On the broader pattern of funding AI infrastructure through equity and structured instruments, our earlier analysis of CoreWeave's financing structure offers a comparison case.

 

 

The following remain undetermined as of this article's verification date of October 27, 2026, and are the variables that will decide the eventual dilution.

 

Whether the two over-allotment options are exercised, both running thirty days. The preferred option covers up to 37.5 million depositary shares and the common option up to $3.75 billion, and exercising both would move the priced portion's dilution from roughly 2.23% to roughly 2.70%.

 

The actual settlement timing and price adjustments on the forward sale agreements. Settlement dates are Meta's to specify, no later than November 19, 2027, and the forward price is subject to the agreements' adjustment provisions, so the eventual proceeds may differ from the roughly $24.9 billion estimate.

 

The date Class C shares begin trading, along with the record and payment dates for the stock dividend. None of the three has been announced, and the ATM's start depends on that trading date.

 

The signing, final size and pricing mechanism of the ATM programme. At present it has only an indicated ceiling of $60 billion, with no agreement, and it does not appear in the pricing announcement.

 

The actual purchases by Nvidia, AMD and Broadcom. Their indications total up to $5.0 billion and are non-binding.

 

The form in which preferred dividends are paid. The board may elect cash, Class A common stock or a combination, and electing stock would create additional dilution.

 

Readers following stock perpetual contracts should be clear that such contracts are derivatives whose holders receive no shares, voting rights or dividends, and therefore participate in none of these offerings, conversions or dividend arrangements, with pricing that tracks only the underlying share price. On MEXC, review the contract rules, leverage tiers and position limits for the META stock perpetual, and check the trading sessions and risk limits for the instrument before submitting an order.

 

 

For James Mitchell, summarising this as "Meta raises $95 billion" almost guarantees a misreading, because the figure adds together three things of entirely different character.

 

What actually arrives is $12.5 billion, on October 29. The $25.0 billion common stock portion runs through forward sale agreements under which Meta explicitly does not expect proceeds from the initial sales, collecting roughly $24.9 billion only on settlement dates of its own choosing, no later than November 19, 2027. The $60 billion ATM has no agreement, is not expected before the first quarter of 2027, and must wait for Class C shares to start trading, a date still unannounced. Adding those three gives a maximum authorisation, not a quantity of money.

 

The structure most worth studying here is the forward sale agreement. It locks in the economic terms of the shares at today's price while deferring both the cash inflow and the share issuance, with the settlement date left to the company. For the company that is cash management flexibility. For existing shareholders it means the economic effect of the dilution was established on the pricing date while the share count increase will not appear for more than a year. Anyone reading only the outstanding share count will "discover" this dilution in 2027.

 

The mandatory convertible's terms repay line-by-line reading too. The 6.50% dividend rate works out to roughly $810 million a year on the $12.5 billion size and may be paid in cash or in Class A common stock, the latter adding dilution. More consequential is the 1.3620 to 1.6000 conversion range. Derived from the liquidation preference, 1.6000 corresponds to $625.00, exactly this offering's common price, while 1.3620 corresponds to roughly $734.21, about 17.5% higher. A 2029 price below $625.00 therefore applies the maximum rate and issues the most shares. Put plainly, the heaviest dilution lands when the share price has done worst, which differs fundamentally from a common offering where the count is fixed at issuance. What existing shareholders carry is effectively a dilution exposure that runs inverse to the stock.

 

On whether the raise was necessary, the third-quarter figures answer directly. Capital expenditure of $34.91 billion exceeded operating cash flow of $32.786 billion for the first time, turning free cash flow to negative $2.12 billion against roughly positive $10.6 billion a year earlier, a swing above $12.7 billion in twelve months. Full-year guidance of $135 billion to $145 billion implies fourth-quarter spending of $49.2 billion to $59.2 billion in one quarter. Against that yardstick, the $95 billion maximum covers roughly one and a half to two quarters of spending, and the $12.5 billion arriving in October is under four tenths of a single third-quarter figure. That explains why a $60 billion ATM authorisation is being kept in reserve.

 

One arrangement deserves more discussion than it has had. Nvidia, AMD and Broadcom indicated interest in up to $5.0 billion of Class A shares on the same terms as other investors, non-binding. All three are also principal suppliers to Meta's AI infrastructure. Suppliers participating in a customer's equity raise is not unusual in itself, but when quarterly spending approaches $35 billion, the direction of money inside the supply chain is worth watching. Since the indications are non-binding and may end at zero, the actual scale cannot be judged now, which makes it something to track rather than to assume.

 

A closing note on measurement basis. Meta's capital expenditure guidance and disclosure both use a basis including principal payments on finance leases, and its free cash flow calculation subtracts both property and equipment purchases and finance lease principal. The two bases differ by $964 million in the third quarter, which looks small, but companies do not use a consistent basis when AI capital expenditure is compared across the sector, and ignoring this produces the wrong ordering.

 

 

 

The priced portion totals roughly $37.5 billion, comprising $12.5 billion of mandatory convertible preferred and $25.0 billion of Class A common stock. But only roughly $12.5 billion arrives in October 2026, because the common portion runs through forward sale agreements under which Meta does not expect proceeds from the initial sales, with roughly $24.9 billion arriving on settlement dates of its own specification, no later than November 19, 2027. The third component, an at-the-market programme of up to $60 billion in Class C stock, has no agreement and its timing, size and terms are all undetermined.

 

 

On the 2,556 million shares outstanding as of September 30, 2026, the priced portion dilutes by roughly 2.23% to 2.35%, rising to roughly 2.57% to 2.70% if both over-allotment options are fully exercised. Within that, the 40 million common shares account for roughly 1.56% and the preferred conversion for roughly 17.03 million to 20.0 million shares, or roughly 0.67% to 0.78%. The $60 billion ATM cannot be modelled precisely, though at this offering's $625.00 price it would correspond to roughly 96 million shares, around 3.76%. These percentages are calculations from published terms rather than figures disclosed in the filings.

 

 

Three main differences. On income, the preferred pays a 6.50% annual dividend on the $1,000 liquidation preference, quarterly from February 15, 2027 through August 15, 2029, in cash or Class A common stock, while common stock pays no fixed dividend. On share count, conversion is not fixed, with each preferred share converting into 1.3620 to 1.6000 Class A shares depending on the volume-weighted average price over twenty trading days before conversion, whereas a common share's count is fixed at issuance. On liquidation, the preferred carries a $1,000 per share liquidation preference.

 

 

Because the conversion rate is a range. Derived from the liquidation preference and the rates, the maximum rate of 1.6000 corresponds to $625.00 and the minimum rate of 1.3620 to roughly $734.21. A price below $625.00 at conversion in 2029 applies the maximum rate and issues the most shares, while a price above roughly $734.21 applies the minimum rate and issues the fewest. The share count therefore moves inversely to the price, putting the heaviest dilution in the scenario where the stock has performed worst. Both prices are derived from the terms and are not stated directly in the pricing announcement.

 

 

Third-quarter 2026 capital expenditure of $34.91 billion exceeded the same period's operating cash flow of $32.786 billion for the first time, leaving free cash flow at negative $2.120 billion against roughly positive $10.6 billion a year earlier. Capital expenditure across the first three quarters reached $85.8 billion against $50.1 billion a year earlier. Full-year guidance of $135 billion to $145 billion including finance lease principal implies fourth-quarter spending of roughly $49.2 billion to $59.2 billion. On that scale, the $95 billion maximum corresponds to roughly one and a half to two quarters of capital expenditure.

 

 

There is no set date. The programme is not expected to begin before the first quarter of 2027 and only after Class C shares start trading, but as of this article's verification date no agreement has been signed and the timing, size and terms are all undetermined, with the October 26 pricing announcement making no mention of it. The Class C trading date itself is unannounced: January 19, 2027 is the expected effective date of the amended certificate of incorporation rather than the date the split completes or Class C shares begin trading, and the record and payment dates for the stock dividend have not been announced either.

 

 

Unconfirmed. The three indicated interest in purchasing up to $5.0 billion of Class A shares in aggregate on the same terms as other investors, but the indications are non-binding and they may buy more, less or nothing. Note that all three are also principal suppliers to Meta's AI infrastructure. Actual purchases will need to be confirmed in subsequent filings.

 

 

A stock perpetual is a derivative whose holder receives no shares, voting rights or dividends, and therefore participates in none of the offering, conversion or dividend arrangements and holds no pre-emptive rights. Contract prices track the underlying share price, so any price movement caused by the financing will show up in the contract price, while the corporate actions themselves, including dilution, conversion and dividends, do not act directly on the position. The specific handling is governed by the rules on the contract detail page.

 

 

The information above is provided for general market and product information only and does not constitute investment advice, financial advice, legal advice, tax advice or a recommendation to buy or sell securities, nor does it constitute an endorsement of any issuer or trading product. The offering terms and financial data cited come from Meta Platforms, Inc.'s pricing announcement of October 26, 2026, the prospectus supplement and free writing prospectus filed the same day, and the company's third-quarter 2026 results announcement, verified on October 27, 2026. Figures identified as this article's calculations or derivations, including all dilution percentages and the initial price and threshold appreciation price, are not figures disclosed in the filings; they are calculated from published terms on the share count outstanding as of September 30, 2026, and actual outcomes will differ with the exercise of over-allotment options, the forward price adjustment provisions, future changes in share count and the actual share price at conversion. The at-the-market programme of up to roughly $60 billion has not been agreed, its timing, size and terms are all undetermined, and it should not be treated as funds obtained; proceeds under the forward sale agreements arrive only at settlement, and the company has stated explicitly that it does not expect proceeds from the initial sales. The mandatory convertible's conversion rate is a range rather than a fixed figure, and the declaration and form of dividend payment rest with the board, both of which may affect the eventual share count. Capital expenditure figures use a basis including principal payments on finance leases and are not directly comparable with a basis counting only property and equipment purchases; the company has not published a 2027 capital expenditure figure. The stock perpetual contract referenced is a derivative rather than a share, conferring no ownership, voting rights or dividends and no participation in corporate actions, and leveraged products can produce losses exceeding the initial outlay. Readers should consult the issuer's original filings before making any decision, judge against their own financial circumstances, investment objectives and risk tolerance, and consult a qualified professional where appropriate. The MEXC Crypto Pulse team accepts no liability for any direct or indirect loss arising from the use of this information.

 

 

James Mitchell specializes in technical analysis, market trends, and trading strategies for both Bitcoin and altcoins. Based in London, he has over 10 years of experience in financial markets. Before joining MEXC Learn, James worked as a senior analyst at a leading European investment firm, where he developed expertise in risk management and quantitative trading. His transition to cryptocurrency markets began in 2017, and he has since become recognized for his data-driven approach. He holds a Master's degree in Financial Economics from the London School of Economics. His analytical approach combines traditional technical analysis with on-chain metrics to provide readers with actionable insights.

 

Areas of Expertise: Technical Analysis, Market Trends and Cycles, Trading Strategies, Bitcoin and Altcoin Analysis, Risk Management.

 

 

 

Want the fastest access to MEXC's latest updates? Join our official Telegram group now!

MEXC Platform: Download App | Zero Fee Trading | Buy USDT Now

Join MEXC Community: X (Twitter) | Telegram | Discord

Get Insights: MEXC Learn | Terms of Service | MEXC Blog | MEXC News

Account Verification: Understand KYC | How to Complete KYC

External Content Platforms: Substack | Medium | Paragraph | LinkedIn | X(News)